Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Background Cardiac biomarkers and left ventricular hypertrophy (LVH) are related to the risk of stroke and death in patients with atrial fibrillation. We investigated the interrelationship between LVH and cardiac biomarkers and their independent associations with outcomes. Methods and Results Plasma...

Celý popis

Podrobná bibliografie
Hlavní autoři: Ziad Hijazi, Paolo Verdecchia, Jonas Oldgren, Ulrika Andersson, Gianpaolo Reboldi, Giuseppe Di Pasquale, Giovanni Mazzotta, Fabio Angeli, John W. Eikelboom, Michael D. Ezekowitz, Stuart J. Connolly, Salim Yusuf, Lars Wallentin
Médium: Článek
Jazyk:English
Vydáno: Wiley 2019-01-01
Edice:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Témata:
atrial fibrillation
biomarker
left ventricular hypertrophy
risk prediction
On-line přístup:https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

Podobné jednotky